Study: Medicare drug plans vary in costs, coverage

Out-of-pocket drug costs and medication access vary widely among Medicare prescription drug plans, according to a Kaiser Family Foundation study.

Investigators examined 35 drug plans offered by 14 organizations. The plans, on average, covered 81% of the 152 drugs seniors use most often. Overall, percents ranged from 64% to 97%.

Out-of-pocket costs also covered a wide range. For example, out-of-pocket costs for the arthritis drug Fosmax ranged from $15 to $100. For the arthritis drug Enbrel, the range was even wider: $20 to $1,276. Plans also varied in their use of quantity limits, prior-authorization requirements and step-therapy provisions.

More in News

Senate bill seeks to empower long-term care ombudsmen, strengthen eldercare workforce

Senate bill seeks to empower long-term care ombudsmen, ...

Senate lawmakers are seeking to strengthen and expand the long-term care ombudsman program and boost the eldercare workforce through a bill to reauthorize the Older Americans Act of 1965. The ...

CMS: Providers may need to reimburse beneficiaries due to inaccurate therapy denial ...

Therapy providers should review therapy cap denials for 2013 and refund any beneficiary payments for these services, according to a Medicare newsletter released Thursday.

Court upholds $5.75 million verdict against former nursing home officers, board members ...

A $5.75 million verdict will stand and there will be no new trial in the case against officers and board members of a former Pennsylvania nursing home, a federal judge recently ruled.